News & Media

January – March Financial summary for the quarter Net turnover amounted to SEK 9.9 (7.3) million. The loss before interest, tax,...

Press release 2021/04/20

Medivir to participate at the Kempen Life Sciences Conference

Stockholm, Sweden — Medivir AB (Nasdaq Stockholm: MVIR) today announces that the company will participate at the virtual meeting Kempen Life...

Press release 2021/04/19

Medivir has determined the starting dose for the next part of the phase Ib study with MIV-818

Stockholm, Sweden — Medivir AB (Nasdaq Stockholm: MVIR) today announced that the last patient has undergone the safety follow-up to identify...

Press release 2021/04/16

Medivir appoints Magnus Christensen as interim CEO

Stockholm, Sweden — Medivir AB (Nasdaq Stockholm: MVIR) announced today that its Board of Directors appoints Magnus Christensen, the company’s CFO,...

Press release 2021/04/06

Medivir 2020 Annual Report published

Stockholm, Sweden - Medivir AB (Nasdaq Stockholm: MVIR) today announces that the Annual Report for 2020 now is available at the...

Press release 2021/03/31

Number of shares and votes in Medivir

Stockholm — Medivir AB (Nasdaq Stockholm: MVIR) today announces that the number of shares and votes in Medivir has changed during...

Press release 2021/03/29

Notice of Annual General Meeting of Medivir AB (publ)

The shareholders of Medivir AB, reg. no. 556238-4361, with its registered office in Huddinge, Stockholm, are hereby summoned to the annual...

Press release 2021/03/25

Last patient with liver cancer included in the monotherapy part of Medivir's phase Ib study with MIV-818

Stockholm, Sweden — Medivir AB (Nasdaq Stockholm: MVIR) today announced that the last patient with advanced liver cancer has been included...

Press release 2021/03/22

Changes in Medivir’s management and Board of Directors

Stockholm, Sweden — Medivir AB (Nasdaq Stockholm: MVIR) today announces that Yilmaz Mahshid leaves the position as CEO of Medivir. The...

Press release 2021/03/11

Resolution at the extraordinary general meeting in Medivir on 11 March 2021

Resolution on a directed issue of shares The extraordinary general meeting in Medivir Aktiebolag (publ) on 11 March 2021 resolved, in...

Press release 2021/03/08

Medivir to present at the H.C. Wainwright Global Life Sciences Conference

Stockholm, Sweden — Medivir AB (Nasdaq Stockholm: MVIR) today announces that the company will present at the virtual meeting H.C. Wainwright...

Press release 2021/02/26

MEDIVIR AB – YEAR-END REPORT JANUARY – DECEMBER 2020

October – December Financial summary for the quarter Net turnover amounted to SEK 1.5 (1.4) million. The profit before interest, tax,...